| Finding | Percentage | Cases |
|---|---|---|
| Gender | ||
| Male | 66.7% | 20/30 |
| Female | 33.3% | 10/30 |
| Indifferent | 0% | 0/30 |
| Unknown | 0% | 0/30 |
| General | ||
| 3.3% | 1/30 | |
| 6.7% | 2/30 | |
| 3.3% | 1/30 | |
| 26.7% | 8/30 | |
| 16.7% | 5/30 | |
| 6.7% | 2/30 | |
| 56.7% | 17/30 | |
| 70% | 21/30 | |
| 70% | 21/30 | |
| 83.3% | 10/12 | |
| Neurology | ||
| 70% | 21/30 | |
| 80% | 24/30 | |
| 26.7% | 8/30 | |
| Facial abnormalities | ||
| 20% | 6/30 | |
| 13.3% | 4/30 | |
| 16.7% | 5/30 | |
| 16.7% | 5/30 | |
| Visual and hearing impairments | ||
| 3.3% | 1/30 | |
| 30% | 9/30 | |
| Heart | ||
| 16.7% | 5/30 | |
| Pulmonary | ||
| 6.7% | 2/30 | |
| Gastrointestinal | ||
| 33.3% | 10/30 | |
| Urogenital | ||
| 6.7% | 2/30 | |
| Skeleton | ||
| 33.3% | 10/30 | |
| Skin / Hair / Nails | ||
| 23.3% | 7/30 | |
| Endocrine / Immunological / Metabolic | ||
| 6.7% | 2/30 | |
| 20% | 6/30 | |
| 10% | 3/30 | |
| Neoplasia | ||
| 6.7% | 2/30 | |
| Inheritance | ||
| 100% | 2/2 | |
